NU2GGH002417
Cooperative Agreement
Overview
Grant Description
Action to Sustain Precision and Integrated HIV-Response Towards Epidemic Control (ASPIRE) Project
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Nigeria
Geographic Scope
Foreign
Analysis Notes
Amendment Since initial award the total obligations have increased 728% from $11,703,201 to $96,854,044.
Institute Of Human Virology Nig Ltdgte was awarded
ASPIRE Project: Precision Integrated HIV-Response Epidemic Control
Cooperative Agreement NU2GGH002417
worth $96,854,044
from Center for Global Health in September 2022 with work to be completed primarily in Nigeria.
The grant
has a duration of 5 years and
was awarded through assistance program 93.067 Global AIDS.
The Cooperative Agreement was awarded through grant opportunity Delivering Comprehensive and Sustainable HIV/AIDS Clinical and Community Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR).
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
9/30/22
Start Date
9/29/27
End Date
Funding Split
$96.9M
Federal Obligation
$0.0
Non-Federal Obligation
$96.9M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU2GGH002417
Additional Detail
Award ID FAIN
NU2GGH002417
SAI Number
NU2GGH002417-3834834899
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CW00 CDC CENTER FOR GLOBAL HEALTH
Awardee UEI
VDS1HPNCNMN5
Awardee CAGE
SGQ15
Performance District
Not Applicable
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Global Health Programs, State (019-1031) | International development and humanitarian assistance | Grants, subsidies, and contributions (41.0) | $57,129,685 | 100% |
Modified: 9/24/25